The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Well that dip will not last long, we are rising quickly now! Next step over £2!
The ‘Fear Of Missing Out’ will mean that few long term investors will trade at this point. The big RNS’s can drop at any point now. Not necessarily at 7am. When they do it will jump hugely.
I think a strong afternoon is more than possible!
Cheers Rich
Good morning all!
There is huge expectation now and we know that we are so close to the announcement of two highly significant tests, both have the ability to massively ramp up testing in the UK and around the world. Both are highly likely to send our SP much much higher. The details of the tests and the production capacity, the initial sales and the partnerships are all going to need to expand to meet the ever growing demand.
If ever a companies share price was so clearly signposted as about to rise dramatically based on news incoming, I have not seen it.
The next 4 months could make this the most talked about share on the London market!
Let’s see how this plays out!
Have a very good week all!
Cheers Rich
....this is going to be the most important week in Avacta’s journey so far? Could we be about to see the most important development in the UK’s Covid19 fight announced this week?
I hope so! If we do then we could double this week!
Cheers Rich
The target for Charlotte is getting closer! Only £32k to get her to the treatments she needs. Great effort across many boards on LSE! The generosity of people is outstanding. She needs all the help she can get.
Thanks for the kind words. My good lady has made amazing progress but the long term effects will be with her for life. She is so brave as so many are when they have been through long term cancer treatments and major surgery.
When we started to research Avacta and the details surrounding targeted chemotherapy care up, she asked me to sell all her other investments and go all in with Avacta. I dutifully did so at around 35 pence. She has a very good holding in her own right!
With the long term prospects here over the next 18 months with the multiple revenue streams, I am sure she made the right decision and she thought I should do the same. She was right, as all good ladies are! I still haven’t do so, but I am very happy with our holding especially given £10, £20 or even much higher per share is looking very likely indeed.
One thing my good lady has always looked out for others. When she was in intensive care she always asked about every other patient around her! She always said she was glad it was her with her cancer and not her family and friends. She remains the most precious gift in my life! A true inspiration.
Remember health is your most important thing!
Her faith is her most important thing!
Makes you think.
Cheers Rich
Spike66, I am sure the company will have underlined the point that they are trying to work within market guidelines to ensure that publicity must be held off until Avacta’s official announcement via an RNS. There are many times when a media block is put in place until official announcements are made. Rumours and inclination are what we all have now. The company via Alastair Smith have been very clear on giving expectations on the performance of our test, the exciting and encouraging preliminary results and his expectations on sales. Even the initial sales price. Put this all together and you have a huge potential upside when that RNS comes.
Bring this RNS out linked with promised sales and initial production targets and you have the opportunity to see one if the most important Covid19 testing revolutions on the planet!
I am even thinking they may bring the BAMS out either on the same day or even afterwards.
But, what ever the order, I think this week may be the week we hear the first official news.
I still underline, especially with the fund raise for young Charlotte over the weekend, that the importance of the success of targeted chemotherapy will once and when it is able to be implemented be one of the most important developments in oncology in recent years and the potential for repeated market jumps as each form of chemotherapy pre|CISION delivery system is approved Avacta has the potential to be the most important Biotech company in the UK ever and one of the most valuable if they can build without being acquired by a pharmaceutical giant!
We are only 18 months away potentially from seeing this realised.
I remind everyone to watch the annual presentation from July to see the full picture. https://webcasting.brrmedia.co.uk/broadcast/5e985bc231da814c9fc6a477
Avacta has a huge future ahead. Right time and right place with a revolutionary patented IP in Affimer Technology.
Cheers Rich
I am sure Charlotte and her family will be more than grateful for all who have donated to help her.
If you missed the link and care spare something to help here is the link again.
https://www.gofundme.com/f/nq6xu-help-charlotte?viewupdates=1&rcid=r01-159809370261-9a25d9042f064fb6&utm_medium=email&utm_source=customer&utm_campaign=p_email%2B1137-update-supporters-v5b
I can from experience say that the kindness, love and prayers of others is overwhelming at tough times. My wife has gone through so much and has made really good progress. We have tried to help and support as many others going through difficulties since. Finacial support is one of the key needs for Charlotte now, but we have seen real answers to prayer to, so if you have a moment please do this for Charlotte too.
Thanks to everyone for there support and help!
Rich
Sorry here is the link - https://www.gofundme.com/f/nq6xu-help-charlotte?viewupdates=1&rcid=r01-159809370261-9a25d9042f064fb6&utm_medium=email&utm_source=customer&utm_campaign=p_email%2B1137-update-supporters-v5b
Thanks to all those adding and donating to this important cause. Cancer effects so many families, but it is even harder when the loved one is so young.
I know the family and friends of Charlotte will be for ever grateful.
Thank you! Rich
Projectory towards £10 before Christmas and the successful stage 1 pre|CISION chemotherapy test add a minimum of another £5 to the share price.
There are multiple influences here and total success will take this to levels beyond anything anyone realises.
Cheers Rich
Milkman87 - I have just shared on the Avacta board. There are many investors there because of the development for targeted chemotherapy and all of us effected by cancer are touched with the efforts to help young Charlotte, so I trust they will support this special cause.
I truly hope you are able to get to the special number to get the treatment that Charlotte needs.
Cheers, Rich
Talking of cancer treatment. I have a request on behalf of a friend who is invested on one of my other investments. This young lady needs our help! If you have a spare amount you can contribute it would be massively appreciated! I have donated and I hope you maybe able to as well! She has a very aggressive form of cancer and can only get treatment in the US.
https://www.gofundme.com/f/nq6xu-help-charlotte?viewupdates=1&rcid=r01-159809370261-9a25d9042f064fb6&utm_medium=email&utm_source=customer&utm_campaign=p_email%2B1137-update-supporters-v5b
Thanks very much!
Rich
The consideration that a human really produces antibodies to Covid19 is most likely going to be proven to be a myth. It is more likely that some people may have some immunity which means the virus has little effect. But, there are many vulnerable people in the world who have low immunity and are are significant risk and infection will most likely result in a high risk of death. The real future revolutionary discovery will be to diagnose those who have inbuilt immunity to SAR-COV2 or those who remain at serious risk. Targeted vaccination and even use of the virus blocker could be used and bring life back to normal.
Until then testing the mass populous is the only way.
Avacta holds the key in offering many solutions to the fight in getting Covid under control.
But for me the long term real value cones from target chemotherapy from the multiple projects using Avacta's pre|CISION 'warhead' high concentration chemotherapy tumour destroyer! The global impact for those who develop cancer will be massive! The value to this business will be similar. Massive. If you are invested here then if you need a long therm investment with huge potential look at the impact of delivering this solution. The live saving ability and the reduction in cost for global hospitals in care and time will be off the scale. Those clinical tests can't come soon enough and especially for those suffering with cancer today.
Lets hope they can deliver the pre|CISION solutions very soon!
Cheers, Rich
The LFD should be incinerated and can be used to make power! The amount of polymer included is only a few grams in the case. The material is a PP grade, but the insert is unknown to me at this time. But it can be burned and produces high calorific energy! Safe collection and recycling is very important.
Altlantis Energy would be a great partner to recycle the LFD.
Cheers Rich
This report on the BBC points to the virus being around forever!
Coronavirus will be with us forever, Sage scientist warns https://www.bbc.co.uk/news/uk-53875189
Given reoccurring flu, colds which are forms of Corona Virus it is totally believable. The question is how servere will be the ongoing symptoms and will our Virus blocker be able to not only block the SARS-CoV2 strains but could it be modified to kill annual flu and cold symptoms? Imagine a self control injection COVID jab to block any COVID strain. Avacta could develop such a drug with Affimer technology!
The possibilities are endless!
Cheers Rich
This news report underlined the issues of companies that regulate their own Antibodies tests.
Coronavirus antibodies tests 'put public at risk' https://www.bbc.co.uk/news/health-53853967
The imminent news coming from Avacta on a super accurate Antigen test with results in less than 10 minutes which is fully tested by independent and government regulated and controlled scientists is going to be critical traction for both Avacta tests. Doing it right is critical.
So pleased that we have selected Avacta for a key part of our future investment portfolio!
Cheers Rich
I am sure all share holders are delighted to see the pick up in the share price following the UK health secretaries comments yesterday. Many investors were really wondering if the promise and the potential could be realised. As is always the case with AIM shares people are very fickle and usually impatient. During lock down it was very easy to focus on Covid shares and see immediate potential, but here in the UK as life has returned to 'semi-normality' it is a bit of a haze. But the world has a serious problem and testing is a major help, but mass testing is the real way to trace and isolate. The Rapid POC LFD from Avacta is going to be I am sure the most important step forward. It seems a sure thing that the initial production will be 100% purchased by governments. BBi will have limited capacity which is highly unlikely to meet the total need. If they are investing in more assembly machines and productivity optimisation it is unclear. But one thing which is clear Avacta are going to need multiple partnerships for production. The impact of a USA based manufacturing partner is going to huge too. This is an announcement which will really wet the appetite and mass orders from the US, and South America which has a huge need too opens up a mass potential which is going to bring huge income to Avacta if the expected take up is able to be met.
I am thinking the time gap now from BAMS going live and POC LFD going live maybe very short indeed.
The growth curve for share price appreciation is looking even stronger than any of us considered. Numbers around the world are really going to be off the scale. People talk of the fear of missing out and news really could come at any time.
I remember a Friday afternoon in April when Novacyt jumped from £2.50 to nearly £5 in less than an hour. The impact here will be equally strong but more likely to last for much longer. A test result in less than 10 minutes is going to have a much larger impact.
Theses tests will be selling for months even years in massive numbers. The perfect flexible option for Avacta they will be able to modify the test easily for ant mutations in the virus. The Affimer generation of diagnostics and therapeutics is about to go mass market!
Have a great evening all!
Cheers Rich
PS - Who knows where our value will go? Today Tesla has topped $2000 per share! No, I don't expect a valuation of $375 billion, but we are heading to the one billion pound very soon!